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SUMMARY
The polymorphism ATG16L1 T300A, associated with
increased risk of Crohn’s disease, impairs pathogen
defense mechanisms including selective autophagy,
but specific pathway interactions altered by the risk
allele remain unknown. Here, we use perturbational
profiling of human peripheral blood cells to reveal
that CLEC12A is regulated in an ATG16L1-T300A-
dependent manner. Antibacterial autophagy is
impaired in CLEC12A-deficient cells, and this effect
is exacerbated in the presence of the ATG16L1*300A
risk allele. Clec12a/ mice are more susceptible to
Salmonella infection, supporting a role for CLEC12A
in antibacterial defense pathways in vivo. CLEC12A
is recruited to sites of bacterial entry, bacteria-
autophagosome complexes, and sites of sterile
membrane damage. Integrated genomics identified
a functional interaction between CLEC12A and an
E3-ubiquitin ligase complex that functions in anti-
bacterial autophagy. These data identify CLEC12A
as early adaptor molecule for antibacterial auto-
phagy and highlight perturbational profiling as a
method to elucidate defense pathways in complex
genetic disease.
INTRODUCTION
Genome-wide association studies (GWASs) have emerged as a
powerful non-biased technique for identifying pathways related
to human diseases with complex genetic architecture. Under-
standing such complex diseases requires a broad understanding
of the relevant functional nodes regulating disease-relevant path-
ways. Genes do not function in isolation, and it is clear that
both gene-gene and gene-environment interactions contribute
to disease susceptibility (Barreiro et al., 2012; Cadwell et al.,
2010; Silver et al., 2013). More than 140 genetic risk loci have
been identified for Crohn’s disease, a chronic inflammatory con-
dition affecting the gastrointestinal tract (Franke et al., 2010; Jos-
tins et al., 2012). These studies have highlighted the contribution
of multiple immune and cellular pathways to Crohn’s disease
pathogenesis, particularly those involved in microbial defense
(Jostins et al., 2012; Lassen et al., 2014; Murthy et al., 2014; Sa-
daghian Sadabad et al., 2014).
ATG16L1 (autophagy-related protein 16-like 1) is a component
of the core autophagy machinery, and the ATG16L1 T300A
polymorphism confers a modestly increased susceptibility to
Crohn’s disease despite its relatively high prevalence in the
population (Franke et al., 2010). Autophagy is a pro-survival
intracellular degradation pathway that functions as a key medi-
ator of a number of processes including central metabolism,
cell signaling, cell death, and carcinogenesis, as well as both
innate and adaptive immunity (Deretic et al., 2013; Yang and
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Klionsky, 2010). The ATG16L1 T300A polymorphism has been
associated with both impaired antibacterial autophagy and
altered production of cytokines by peripheral blood mononu-
clear cells (PBMCs) in response to immune stimuli (Lassen
et al., 2014; Plantinga et al., 2011). Recent studies have demon-
strated that the mechanism underlying these alterations is linked
to increased susceptibility of ATG16L1 T300A to caspase-medi-
ated cleavage and thus lower levels of functional ATG16L1
(Lassen et al., 2014; Murthy et al., 2014).
The autophagy pathway is important for defense against a
number of intracellular pathogens and pathobionts includingSal-
monella enterica serovar Typhimurium, Shigella flexneri, Listeria
monocytogenes, Enterococcus faecalis, and Mycobacterium
tuberculosis (Benjamin et al., 2013; Castillo et al., 2012; Gutierrez
et al., 2004; Huett et al., 2012; Manzanillo et al., 2013; Ogawa
et al., 2005; Tattoli et al., 2012; Thurston et al., 2012). Autophagy
degrades intracellular bacteria and helps to restrict their replica-
tion. In this process, cytoplasmic bacteria are first marked for
degradation primarily by ubiquitination (Deretic et al., 2013).
Recent studies have identified key roles for the E3 ligases
LRSAM1 and PARKIN in recognition and ubiquitination of cyto-
plasmic bacteria; however, there are likely additional cellular
E3 ligases that provide specificity to this pathway (Huett et al.,
2012; Manzanillo et al., 2013). Ubiquitinated bacteria are then
recognized by the adaptor proteins p62, optineurin, and
NDP52, leading to the recruitment of LC3 and the autophagyma-
chinery (Cemma et al., 2011; Thurston et al., 2009; Wild et al.,
2011). The autophagy pathway targets only a subpopulation of
bacteria within a cell, and little is known about the molecules
involved in the selective recognition and targeting of bacteria
for autophagosomal degradation, despite the important patho-
logical consequences of this process.
In this study, we approached the question of the impact of the
ATG16L1 T300A risk variant by searching for associated respon-
siveness quantitative trait loci (reQTLs), which are defined as the
effects of genetic variation on transcriptional responses of cells
(Barreiro et al., 2012). Given that functionally similar genes are
often transcriptionally coregulated, using multiple immune stim-
uli in genetically defined cell populations along with reQTLs has
enabled the identification of differential effects on molecular cir-
cuits (Gat-Viks et al., 2013). In the current study, we perform
stimulus-specific perturbational profiling in PBMCs, quantitative
mass-spectrometry-based (MS) proteomics, and genome-wide
RNA expression analysis to identify antibacterial genes that are
functionally related to ATG16L1. Using these approaches, we
demonstrate a role for CLEC12A in antibacterial autophagy
and pinpoint a functionally relevant interaction node of CLEC12A
with an E3 ligase complex that is important for this function.
RESULTS
Perturbational Profiling Reveals Genotype-Specific
Transcriptional Responses
To identify molecules involved in the ATG16L1-T300A-depen-
dent antibacterial autophagy pathway, we used perturbational
profiling to measure differential gene regulation in the setting of
stimulation with pathogen-associated molecular patterns and
bacterial challenge. Given that mounting evidence indicates an
important role for the involvement of host-microbiota interac-
tions and bacterial defense pathways in Crohn’s disease
(Knights et al., 2013; Lassen et al., 2014; Murthy et al., 2014),
we examined cellular responses triggered upon exposure to
various bacterial products. We selected a panel of three stimuli
to perturb PBMCs from healthy individuals homozygous for
the ancestral ATG16L1*300T allele or the *300A risk allele
(rs2241880). The NOD2 ligand muramyl dipeptide (MDP) was
selected based on the previous association of this stimulus
with Crohn’s-disease-specific pathways (Hugot et al., 2001; Ino-
hara et al., 2003; Ogura et al., 2001). MDP can alsomodulate sig-
nals mediated through TLR2 activation, a pathway that has been
implicated in Crohn’s disease and experimental colitis (Netea
et al., 2004; Watanabe et al., 2008). We therefore also used the
TLR2 ligand Pam3Cys, aswell as the bacteriumBorrelia burgdor-
feri, from which these lipopeptides were initially isolated, to elicit
both NOD2-dependent and -independent responses. Using mi-
croarrays to assess genome-wide RNA expression profiles, we
found that baseline gene expression was similar between indi-
viduals harboring the non-risk and risk alleles. Furthermore,
upon exposure to innate immune ligands, we observed strong
genotype-independent induction of proinflammatory cytokines
and chemokines after hierarchical clustering (Figures 1A and
S1A). To identify reQTLs (Barreiro et al., 2012), we next used
factorial design analysis to examine whether transcriptional re-
sponses to Pam3Cys, Borrelia, or MDP differed between groups
stratified by the *300T non-risk and *300A risk alleles. Using mul-
tiple immune stimuli in genetically defined PBMCs along with
reQTLs has enabled differential effects on molecular circuits to
be determined (Gat-Viks et al., 2013). Our analysis identified 20
ATG16L1*300A-dependent reQTLs under at least one stimula-
tion condition (Figures 1B and S1B). Thus, perturbational
profiling of human immune cells revealed genotype-specific re-
sponses to stimulation.
Multiple T300A-Dependent Differentially Regulated
Genes Are Required for Autophagy Pathways
We focused additional analysis on the autophagy pathway, the
cellular degradation system that has been implicated in risk of
Crohn’s disease byGWASs,which identified predisposing alleles
in ATG16L1 and IRGM (immunity-related GTPase family M)
(Rioux et al., 2007). We and others have reported that the
ATG16L1 T300A polymorphism is associated with impaired anti-
bacterial autophagy aswell as altered production of cytokines by
PBMCs in response to immune stimuli (Lassen et al., 2014; Mur-
thy et al., 2014). Additionally, TLR simulation, particularly through
TLR2, has been shown to induce antibacterial autophagy (Anand
et al., 2011; Delgado et al., 2008; Shin et al., 2010). To determine
whether any of the identified genes might be associated with
autophagy, we generated protein interaction networks anchored
on core autophagy proteins as well as autophagy-associated
components previously identified from a high-confidence inter-
action network derived from a systems-wide autophagy prote-
omics study (Behrends et al., 2010). Of the genes identified,
RAB24 was previously reported to have a direct effect on auto-
phagy (Behrends et al., 2010; Munafo´ and Colombo, 2002),
and three additional gene products (HCK, FEZ1, and FYN) inter-
acted with the autophagy network via known protein-protein
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Figure 1. Perturbational Profiling Reveals Genotype-Specific Transcriptional Responses, Including Differentially Regulated Genes that Are
Required for Autophagy
(A) Gene expression analysis of PBMCs isolated from healthy individuals after infection or stimulation with Borrelia burgdorferi (Bor), MDP, or Pam3Cys (Pam).
Heatmap shows log2 (fold change) relative to mock-treated control.
(B) Heatmap identifying transcripts exhibiting response differences to infection or immune stimuli, stratified by ATG16L1 T300A polymorphism status.
(C) HeLa GFP-LC3 cells were transfected with indicated siRNAs and infected with DsRed-labeled Salmonella. The percentage of GFP-LC3+ Salmonella at 1 hr
post-infection is shown. Data are shown as means ± SD; n = 75 cells per condition from three biological replicates. Data are representative of three independent
experiments.
(D) Representative epifluorescent microscopy images of HeLa cells used to generate data shown in (C). The scale bars represent 10 mm.
(E) Western blot of HeLa cells transfected with the indicated siRNAs and treated with Torin E64D/PepA. Data are representative of three independent
experiments.
(F) CLEC12A rescue constructs indicating positions of synonymous mutations and location of targeting siRNA.
(G) HeLa GFP-LC3 cells were transfected with control siRNA, CLEC12A siRNA1, or CLEC12A siRNA2 as well as CLEC12A rescue constructs (R1 or R2) and
infected for 1 hr with DsRed-labeled Salmonella. Data are shown as mean ± SD; n = 75 per condition. Data are representative of three independent experiments.
(H) HeLa cells from (G) were lysed, and HA-CLEC12A expression levels were assessed by western blot. Data are representative of three independent
experiments.
See also Figure S1.
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interactions (Figure S1C). These observations demonstrate that
the ATG16L1 T300A polymorphism is associated with transcrip-
tional modulation reflecting known protein-protein interactions
with the autophagy network.
Given the previously described role for ATG16L1 and IRGM in
antibacterial autophagy (Singh et al., 2006), we next used siRNA
to evaluate whether any of the identified ATG16L1*300A-depen-
dent reQTLs affected antibacterial autophagy. Of the 20 genes
identified, 13 had detectable expression in HeLa cells and
were suppressed by single siRNAs (Figure S1D). Antibacterial
autophagy was assessed in siRNA-treated cells using infection
with S. Typhimurium, a model pathogen that is degraded by
autophagy (Birmingham et al., 2006). Knockdown of three of
these genes (CLEC12A, RAB24, and EVI2B) resulted in signifi-
cantly decreased Salmonella-autophagosome colocalization
(Figures 1C, 1D, and S1E).
We next tested whether RAB24, EVI2B, or CLEC12A play a
role in classical autophagy using an LC3 flux assay, in which
levels of lipidated LC3-II are compared to LC3-I by western
blot. In this assay, an increase in the ratio of LC3-II to LC3-I cor-
responds to an increase in autophagic flux. Knockdown of
RAB24 and EVI2 resulted in decreased LC3-II accumulation
when cells were treated with Torin 1, an mTOR inhibitor and
inducer of bulk autophagy, suggesting that these genes are
involved in classical autophagy; knockdown of ATG16L1 served
as a control in these experiments. Knockdown of CLEC12A did
not impair LC3-II accumulation under these conditions, suggest-
ing that CLEC12A functions specifically in antibacterial auto-
phagy (Figure 1E) (Thoreen et al., 2009). Additionally, to confirm
that the antibacterial autophagy phenotype seen with CLEC12A
knockdown was not due to off-target effects, we employed a
knockdown rescue approach (Huett et al., 2012) by generating
two siRNA-resistant constructs that express full-length
CLEC12A during knockdown of endogenous gene expression
(Figure 1F). The autophagy defect caused by siRNA against
CLEC12A was rescued by overexpression of the appropriate
CLEC12A construct (Figures 1G and 1H), demonstrating that
the decrease in antibacterial autophagy was specific to a reduc-
tion in CLEC12A expression and not due to off-target effects of
siRNA. Additionally, siRNA targeting CLEC12A did not alter bac-
terial entry, suggesting the observed effect was specific to the
autophagy pathway (Figure S1F).
CLEC12A Knockdown and the ATG16L1 T300A SNP Act
Additively to Impair LC3-Bacteria Colocalization
Given our findings that immune cells harboring the
ATG16L1*300A allele exhibited reduced induction of CLEC12A
under immune stimulation conditions and that CLEC12A is
required for efficient LC3-Salmonella colocalization (Figure 1),
we next investigated whether a genetic interaction exists be-
tween the ATG16L1 T300A SNP and CLEC12A with respect to
antibacterial autophagy. To investigate this hypothesis, we
generated an ATG16L1 knockout (KO) HeLa cell line using the
CRISPR-Cas9 system (Ran et al., 2013). Loss of ATG16L1
expression was confirmed in single HeLa clones (Figure S2A).
As expected, ATG16L1 KO cells were unable to convert LC3-I
to LC3-II under basal or stimulatory conditions (Figure S2B)
and had negligible LC3-bacteria colocalization (Figure 2). To
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Figure 2. CLEC12A Knockdown and the ATG16L1 T300A SNP Act
Additively to Impair LC3-Bacteria Colocalization
(A) Representative epifluorescent images showing impaired antibacterial
autophagy in ATG16L1 KO HeLa cells complemented with the indicated
ATG16L1 protein in the presence of control siRNA or CLEC12A siRNA. The
scale bars represent 10 mm.
(B) Percentage of LC3-Salmonella colocalization in WT HeLa cells, ATG16L1
KO HeLa cells, and ATG16L1 KO HeLa cells stably expressing ATG16L1*300T
or *300A alleles in the presence of control siRNA or CLEC12A siRNA. Data are
shown as means ± SD; n = 75. Data shown are representative of three inde-
pendent experiments.
See also Figure S2.
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determine the effect of the T300A coding polymorphism, we sta-
bly transduced ATG16L1 KO cells with *300T (ATG16L1 KO +
ATG16L1*300T) or *300A (ATG16L1 KO + ATG16L1*300A)
alleles, achieving equivalent expression levels of ATG16L1 in
these lines (Figure S2A). As expected, we found that basal
autophagy was restored in both ATG16L1 KO + ATG16L1*300T
and ATG16L1 KO + ATG16L1*300A cell lines, with modest
impairment of antibacterial autophagy in the ATG16L1 KO +
ATG16L1*300A cells, consistent with published findings (Fig-
ure 2) (Conway et al., 2013; Lassen et al., 2014; Murthy et al.,
2014). Targeting CLEC12A with siRNA resulted in impaired
antibacterial autophagy in the ATG16L1 KO + ATG16L1*300T
cell line similar to WT cells. We observed a more-pronounced
impairment in ATG16L1 KO + ATG16L1*300A cells, suggesting
functional interaction of the T300A polymorphism and reduced
CLEC12A expression.
Clec12a/ Mice Are More Susceptible to Salmonella
Infection In Vivo
CLEC12A is a C-type lectin receptor (CLR) belonging to a family
of transmembrane proteins that recognize pathogen-associated
molecular patterns and engage downstream immune signal
transduction pathways (Dambuza and Brown, 2015; Osorio
and Reis e Sousa, 2011). CLEC12A is highly expressed in human
myeloid cells (Figure S3A), and targeting antigen to CLEC12A re-
sults in enhanced antigen presentation on dendritic cells in mice
(Lahoud et al., 2009; Marshall et al., 2006). Recent studies have
demonstrated that CLEC12A binds to uric acid crystals and
helps to dampen inflammation through its ITIM motifs; however,
it remains unclear whether this is the only ligand for CLEC12A
(Neumann et al., 2014).
To determine whether CLEC12A plays a role in pathogen de-
fense in vivo, we used Clec12a/ mice. Bone-marrow-derived
macrophages (BMDMs) from WT or Clec12a/ mice were in-
fected with a strain of Listeria (EGDe) known to be susceptible
to autophagy in primary macrophages (Anand et al., 2011; Bir-
mingham et al., 2007; Huett et al., 2012). Consistent with the
Salmonella infection results in siRNA-treated cells, Clec12a/
BMDMs displayed lower levels of bacterial colocalization with
LC3comparedwithWTBMDMs (Figures3Aand3B).Additionally,
Clec12a/ BMDMs did not show differences in Torin-1-induced
autophagy, suggesting that bulk autophagy is normal in these
cells (Figure S3B). Taken together, these data suggest that
CLEC12A functions selectively in the antibacterial autophagy
pathway for multiple pathogens in both mouse and human cells.
We next investigated whether CLEC12A plays a role during
infection with intracellular pathogens in vivo. WT or Clec12a/
mice were pre-treated with streptomycin and then infected
with Salmonella (Conway et al., 2013). Four days post-infection,
stool was collected from infected mice and colony-forming units
(cfus) were measured. Clec12a/ mice had significantly higher
cfu levels compared to WT mice (Figure 3C). Clec12a/ mice
also exhibited increased systemic bacterial dissemination as as-
sessed bymeasuring cfus in spleens (Figure 3D). This increase in
cfu was associated with a more-severe clinical disease score as
assessed by overall appearance, piloerection, mobility, and
posture (Figure 3E), as well as decreased survival (Figure 3F).
Taken together, these data suggest that CLEC12A plays a role
in intracellular microbial defense both in vitro and in vivo.
CLEC12AAssociates with Bacteria Early after Entry into
Host Cells and Restricts Intracellular Bacterial
Replication
To further demonstrate the precise role for CLEC12A in anti-
bacterial autophagy, we next tested whether knockdown of
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Figure 3. Clec12a/ Mice Are More Susceptible to Salmonella
Infection In Vivo
(A) Confocal micrographs of LC3-Listeria colocalization in WT and Clec12a/
BMDMs at 1 hr post-infection. The scale bars represent 10 mm.
(B) Quantification of LC3-Listeria colocalization in WT and Clec12a/
BMDMs. Data shown represent mean ± SD of n = 3 independent experiments;
unpaired t test. **p < 0.01.
(C and D) Salmonella cfus quantified per gram of stool (C) and per organ (D) at
4 days post-infection are displayed. Data are shown asmean ±SD; **p% 0.01.
Data are representative of at least two independent experiments (n = 9 for WT;
n = 7 or 8 for Clec12a/).
(E) Clinical score for infected mice at 4 days post-infection. Data are shown as
mean ± SD. Data are representative of at least two independent experiments.
****p < 0.0001; unpaired t test. (n = 14 for WT; n = 13 for Clec12a/).
(F) Survival curve for infected WT and Clec12a/ mice (n = 9 mice per
genotype).
See also Figure S3.
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CLEC12A altered intracellular bacterial replication. Using knock-
down of ATG16L1 as a positive control, we found that knock-
down of CLEC12A in HeLa cells resulted in significantly
increased intracellular replication of Salmonella (Figure 4A),
demonstrating that CLEC12A is required for restriction of intra-
cellular bacterial replication.
Next, we determined whether CLEC12A localizes to bacteria
within cells. GFP-CLEC12A (Figures 4B and 4C) and endoge-
nous CLEC12A (Figure S4A) were predominantly membrane
associated and could be found surrounding intracellular
DsRed-labeled Salmonella at both early and late time points
after infection. Association of CLEC12A with Salmonella peaked
at 30 min post-infection and declined gradually, whereas
LC3-Salmonella colocalization peaked 60 min after infection,
consistent with previous data (Figure 4B) (Huett et al., 2012).
Live cell imaging confirmed that GFP-CLEC12A surrounds bac-
teria and then dissociates at approximately 1 hr post-infection
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Figure 4. CLEC12A Associates with Bacte-
ria Early after Entry into Host Cells and
Restricts Intracellular Bacterial Replication
(A) Gentamicin protection assay in HeLa cells
showing fold replication of Salmonella in cells
treated with the indicated siRNAs. Data are shown
as mean ± SD; n = 6. Data are representative of
four independent experiments.
(B) Quantitation of CLEC12A-bacteria and LC3-
bacteria colocalization at indicated time points.
Data are shown as mean ± SD; n = 3 independent
experiments.
(C) Representative confocal micrographs of HeLa
cells showing association of intracellular bacteria
with GFP-CLEC12A at 20, 40, 60, and 80min post-
infection. The scale bars represent 10 mm.
See also Figure S4.
(Figure S4B), consistent with the time
course of peak LC3 colocalization. Given
the early association of CLEC12A with
bacteria, we next determined whether
CLEC12A was present at sites of bacte-
rial entry into the host cell. We found
that GFP-CLEC12A colocalized with bac-
teria and ruffled actin, an indicator of
recent bacterial entry, suggesting that
CLEC12A associates with bacteria
concomitant with bacterial cellular entry
(Figure S4C) (Lhocine et al., 2015).
CLEC12A Colocalizes with
Autophagosome Proteins
Next, we investigated whether CLEC12A
colocalizes with markers of antibacterial
autophagy. We confirmed that CLEC12A
colocalizes with Salmonella and Rab5, a
marker of early endosomes (Figure S5A).
However, CLEC12A recruitment was
also readily detected around Salmonella
without colocalization of Rab5, suggest-
ing that CLEC12A is not exclusively associated with endosomes
(Figure S5A). Next, we evaluated the colocalization of CLEC12A
with galectin 3 and galectin 8, which are both known to bind to
sites of bacterial-induced intracellular membrane damage as
well as sites of sterile membrane damage (Thurston et al.,
2012). CLEC12A colocalized with both galectin 3- and galectin
8-Salmonella complexes (Figure 5A). These data confirm that
CLEC12A associates with bacteria early after infection concom-
itant with membrane damage.
CLEC12A also colocalized with the antibacterial autophagy
adaptor NDP52 (Figure 5B) as well as the autophagosome
proteins GFP-LC3, the ATG8 homolog GABARAPL2, and
ATG16L1 (Figures 5C and 5D). In all cases, these proteins sur-
rounded intracellular bacteria in conjunction with either endoge-
nous CLEC12A or GFP-CLEC12A (Figures 5B–5D). Of note,
expression of GFP-CLEC12A gave a more-intense fluorescent
signal and demonstrated increased levels of CLEC12A puncta
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within the cells, regardless of stimulation or bacterial infection.
Physical interactions between CLEC12A and LC3, GABARAPL2,
and ATG16L1 were also confirmed by co-immunoprecipitation
(Figure S5B). No difference was observed in CLEC12A binding
to ATG16L1*300T compared to *300A.
Next, we investigated the importance of CLEC12A to early
stages in bacterial targeting.We first determinedwhether knock-
down ofCLEC12A altered recruitment of ubiquitin to bacteria. At
1 hr post-infection, siRNA knockdown of CLEC12A significantly
reduced Salmonella-ubiquitin colocalization (Figures 5E and 5F).
Consistent with this observation, recruitment of NDP52 to
Salmonella was also decreased upon siRNA knockdown of
CLEC12A (Figures 5G and 5H). Colocalization of Salmonella
with galectin 3, galectin, 8, and p62 were unchanged in cells
treated with CLEC12A siRNA (Figures S5C–S5E). These data
reveal CLEC12A as an early bacteria-associated factor that
binds to the autophagy machinery and helps initiate antibacterial
autophagy through the ubiquitin-NDP52 pathway.
Recently, CLEC12A has been shown to be a receptor for dead
cells (Neumann et al., 2014). We hypothesized that CLEC12A
could also recognize sites of membrane damage triggered by
vacuolar disruption after bacterial entry (Tattoli et al., 2012; Thur-
ston et al., 2012). To test this hypothesis, we triggered osmotic
damage of endosomes in cells expressing GFP-CLEC12A. Ga-
lectin 3 served as a marker of damaged endosomes (Thurston
et al., 2012). GFP-CLEC12A colocalized with galectin 3 puncta
after hypertonic shock and treatment with polyethylene glycol
(PEG) (Figure 5I). These results demonstrate that CLEC12A is re-
cruited to sites of membrane damage and could explain the high
proportion of CLEC12A recruitment early after bacterial entry.
Integrated ‘Omics Analysis Identifies KLHL9, KLHL13,
and NEDD8 as CLEC12A-Interacting Antibacterial
Autophagy Molecules
To develop a more-integrated model of CLEC12A function in
pathogen response, we utilized time course RNA-seq data and
targeted quantitative proteomics to pinpoint CLEC12A-depen-
dent protein interactions that may be important for pathogen
response. First, we employed 30 RNA-seq to quantify the
transcriptome of Listeria-infected WT or Clec12a/ BMDMs at
various times post-infection. Using this approach, we identified
genes with statistically significant differences (FDR-adjusted q
value % 0.05) in fold-change response to Listeria infection be-
tween WT and Clec12a/ BMDMs at any time point post-infec-
tion (Figure 6A). Of note, expression of LAMP1, a lysosomal
membrane protein and marker of Salmonella-containing vacu-
oles, was significantly downregulated in Clec12a/ BMDMs,
suggesting endomembrane dynamics might be perturbed in
these cells. We next performed clustering and pathway analysis
using an expanded list of 674 nominally significant genes that
were differentially regulated in Clec12a/ BMDMs at baseline
as well as in response to Listeria. Genes were grouped into ten
clusters using Short Time-series Expression Miner (STEM),
where each cluster represents one of the predefined model pro-
files in STEM that capture potential distinct patterns of infection
response (Figure 6B; Table S1) (Ernst and Bar-Joseph, 2006).
Differences in these model profiles represent distinct regulation
patterns of gene expression. Gene ontology enrichment analysis
was applied to assess the functional significance of each cluster
of genes. The top scoring pathway that was differentially
regulated in Clec12a/ BMDMs was the negative regulation of
the intracellular signal transduction pathway that includes key
signaling components such as Ndufs3, Tmem161a, and
Mapkapk5, among others (cluster 2; Table S1). Additionally, anti-
fungal response genes (S100a9, Myd88, and Ptx3; cluster 6)
were also differentially regulated in the Clec12a/ BMDMs. Se-
lective upregulation of glucose transport (Ppbp and Sorbs1;
cluster 7) but downregulation of lipid transport (Scarb1, Slmo1,
and Soat2; cluster 5) in Clec12a/ cells suggested preferential
regulation of metabolism by CLEC12A in response to Listeria
infection. These results highlight the central role of CLEC12A in
pathogen-induced defense pathways and suggest how defi-
ciencies in CLEC12A could result in impaired bacterial defense.
Next,we sought to identify important transcriptional nodes that
control these responses by integrating known transcription fac-
tor-DNA interaction data with our temporal gene expression pro-
files of infectedWT andClec12a/BMDMs into a unifiedmodel.
To identify important regulation points in the CLEC12A pathway,
we used Dynamic Regulatory Events Miner (DREM), which
searches for CLEC12A-dependent bifurcation events, defined
by a transition in which a set of genes that were previously core-
gulated insteadshowdivergent response/regulationprofiles (Fig-
ure S6A) (Schulz et al., 2012). Based on an extension of a hidden
Markov model, the analysis identified EGR1, a transcription fac-
tor involved in transcriptional response to pathogens (de Grado
et al., 2001; McDermott et al., 2011), as the earliest stage regu-
lator that induces CLEC12A-dependent downregulation of spe-
cific genes (Figure S6A). Interestingly, EGR1 is also known to
be induced by either amino acid deprivation or ER stress, which
are both stimuli known to trigger autophagy (Shan et al., 2014).
These data suggest that reduced expression of EGR1 target
genes could contribute to the reduced pathogen response and
autophagic targeting of bacteria in Clec12a/ BMDMs. Other
notable transcriptional regulators identified in our analysis that
are known to be important for pathogen response include
RELA, NFE2, HIF1A, and ARNT2. Taken together, this analysis
suggests that deletion of Clec12a results in an alteration of the
response to pathogens at the transcriptional level and identifies
key regulators involved in this response.
To further understand the role of CLEC12A in antibacterial
autophagy, we next applied an integrated systems approach us-
ing quantitativeMS-based proteomics and coupled these results
with our transcriptomic profiling analysis to uncover functional
CLEC12A interactions relevant to bacterial defense (Figure 6C).
Proteomic interactors were defined as those that demonstrated
significantly increased binding to FLAG-CLEC12A relative to
FLAG vector alone after immunoprecipitation (Table S2). Interac-
tome analysis identified highly connected nodes within the
CLEC12A interactors (Figure S6B). A specific interaction be-
tween CLEC12A and LC3 or ATG16L1 was not identified by
MS-based proteomics; however, this may reflect the fact that a
meaningful interaction between these proteins occurs only under
stimulation and represents a fraction of the total cellular pool of
these proteins. To identify CLEC12A protein interactions that
may lead to the measured transcriptomic changes in response
to bacterial infection, we used a network optimization approach
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Figure 5. CLEC12A Colocalizes with Autophagosome Proteins and Plays a Role in Pathogen Defense
(A–C) Representative epifluorescent images of HeLa cells showing colocalization of (A) CLEC12A (green) and galectin 8 or galectin 3 (red) around intracellular
Salmonella (blue), (B) GFP-CLEC12A (green) and NDP52 (red) around Salmonella (blue), and (C) endogenous CLEC12A (red) and GFP-LC3 (green) around
Salmonella (blue).
(D) CLEC12A or GFP-CLEC12A (green) and GABARAPL2 or ATG16L1 (red) around intracellular Salmonella (blue). Images are representative of three or more
independent experiments.
(E) Representative epifluorescent images of HeLa cells transfected with a control siRNA or a siRNA against CLEC12A and infected with DsRed-labeled
Salmonella for 1 hr.
(legend continued on next page)
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to identify high-probability sub-networks, composed of signaling
and transcriptional factor interaction cascades (Figure 6C) (Ba-
sha et al., 2013). We then used a hypergeometric test to rank
order CLEC12A-interacting proteins with the most significantly
enriched set of target genes within the network to identify rele-
vant functional nodes (Table S3). Some of the key transcriptional
regulators identified in these sub-networks overlapped with
those identified by DREM analysis, including RELA, TP53,
HIF1A, and EGR1. This analysis pinpointed the ubiquitin-like pro-
tein, NEDD8 (neural precursor cell expressed, developmentally
downregulated 8), as both a CLEC12A interactor and a regulator
of EGR1. These results suggest that the interaction between
CLEC12A and NEDD8 is a functional interaction and contributes
to an early CLEC12A-dependent transcriptional response. This
integrated approach also linked an E3 ubiquitin ligase complex
that includes CUL3 (cullin 3) and the substrate adapters KLHL9
(kelch-like family member 9) and KLHL13 (kelch-like family
member 13) to CLEC12A-dependent transcriptional responses
controlled by the transcription factors CEBPB andCEBPD (Table
S3) (Chen et al., 2014). Importantly, proteomic interactome anal-
ysis demonstrated a physical interaction between NEDD8,
KLHL13, CUL3, and KLHL9, indicating that this is a functional
E3 ligase complex that interacts with CLEC12A (Figure 6D).
NEDD8 is a target of some cycle-inhibiting factors (Cifs), which
are virulence factors produced by bacterial pathogens that alter
the host cell cycle (Crow et al., 2012; Jubelin et al., 2010). Cif can
associate directly with NEDD8-modified cullin-RING complexes
and inhibit their activity (Crow et al., 2012; Jubelin et al., 2010).
These results suggest that these E3 complexes could function
to restrict bacterial replication. We therefore investigated
(F) Quantitation of ubiquitin-bacteria colocalization at 1 hr post-infection in cells shown in (E). Data are shown as means ± SEM from three independent
experiments.
(G) Representative epifluorescent images of HeLa cells transfected and infected as in (E).
(H) Quantitation of NDP52-bacteria colocalization at 1 hr post-infection in cells shown in (G). Data are shown as means ± SEM from three independent
experiments.
(I) Representative confocal micrographs of HeLa cells expressing GFP-CLEC12A. Cells were untreated or exposed to hypertonic media containing PEG 1000,
followed by hypotonic shock.
All scale bars represent 10 mm. See also Figure S5.
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Figure 6. Integrated Systems Analysis Identifies KLHL9, NEDD8, and KLHL13 as CLEC12A-Interacting Antibacterial Autophagy Molecules
(A) Gene expression analysis ofWT andClec12a/BMDMs infected with Listeria for the indicated times. Heatmap shows log2 (fold change) relative to uninfected
WT BMDMs at indicated time points. Shown are the top ten most-significant upregulated and downregulated genes in Clec12a/ BMDMs compared to
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(B) Cluster analysis of 674 differentially expressed genes in Clec12a/ BMDMs versus WT BMDMs.
(C) Schematic of integrated proteomic and transcriptomic approach to identify functionally relevant CLEC12A-interacting proteins.
(D) Interactome analysis shows network of proteins identified from quantitative iTRAQ proteomics. Red box highlights the KLHL9-KLHL13-CUL3-NEDD8
complex interaction within the CLEC12A interactome.
(E) HeLa GFP-LC3 cells were transfected with indicated siRNAs for 48 hr and then infected with DsRed-labeled Salmonella for 1 hr. The fraction of GFP-positive
intracellular Salmonella is shown. Data are mean ± SD and are representative of three independent experiments.
(F) Gentamicin protection assay in HeLa cells showing increased intracellular bacterial replication after 48 hr of knockdown of ATG16L1, KLHL9, NEDD8, or
KLHL13. Data shown as mean ± SD; n = 4. Data are representative of three independent experiments.
See also Figure S6 and Tables S1, S2, and S3.
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whether CUL3, NEDD8, KLHL9, and KLHL13 had roles in anti-
bacterial autophagy similar to CLEC12A (Huett et al., 2012; Man-
zanillo et al., 2013). Upon siRNA knockdown in HeLa cells,
KLHL9, KLHL13, and NEDD8 had a dramatic effect on both
LC3-Salmonella colocalization and bacterial replication, consis-
tent with a role for these proteins in antibacterial autophagy (Fig-
ures 6E and 6F).
DISCUSSION
Human genetics provides a powerful tool to identify and under-
stand physiologically relevant host responses to pathogens given
that host-pathogen interactions are known to have a role in many
complex diseases. Gene-gene interactions and environment-
gene interactionsadd to thecomplexityof identifyingcausal genes
and variants from GWAS data, as well as determining how these
variants affect pathogenesis. Pathway-specific perturbational
profiling and integrated systems approaches have previously
been used in genetically defined organisms to identify genetic
nodes of regulation underlying disease (Gagneur et al., 2013;
Gat-Viks et al., 2013; Smith and Kruglyak, 2008; Zhang et al.,
2013). Using this strategy, we uncovered bacteria- and bacte-
rial-ligand-specific programs affected in healthy individuals ho-
mozygous for the T300A polymorphism in the autophagy gene
ATG16L1. Interestingly, 15% of the T300A-dependent response
genes were found to play a role in autophagy pathways, high-
lighting important SNP-pathway interactions.
Our network analysis identified the CLR family member
CLEC12A as a gene that is less responsive upon TLR2 or bacte-
rial stimulation in individuals carrying the ATG16L1 *300A SNP.
Pursuing the functional implication of this SNP-environment
interaction, we identified a role for CLEC12A in antibacterial
autophagy and demonstrated that CLEC12A controls microbial
replication in vitro and in vivo. Using cells engineered to express
the Crohn’s disease non-risk or risk allele of ATG16L1, we inter-
rogated the SNP-gene interaction with CLEC12A to demonstrate
an exacerbated effect on antibacterial autophagy in the setting
of the disease-associated SNP. Importantly, knockdown of
CLEC12A altered both ubiquitin-Salmonella colocalization and
NDP52-Salmonella colocalization. These findings are consistent
with CLEC12A functioning at an early step in the antibacterial
autophagy pathway at the level of pathogen recognition caused
by membrane damage, with ATG16L1 functioning downstream
at the level of autophagosome formation. These data suggest
a model in which individuals who carry the *300A risk allele
have reduced CLEC12A responsiveness that serves to com-
pound defects in antibacterial autophagy. These results highlight
how non-redundant genes in the same pathway can be identified
through ligand-specific transcriptional regulation.
CLRs are a large family of pattern recognition receptors,
many of which are important signaling mediators in antimicro-
bial defense (Drummond and Brown, 2013). CLEC12A was
recently shown to be a receptor for uric acid crystals and
dead cells (Neumann et al., 2014), and we extend this finding
to demonstrate that CLEC12A also recognizes sites of intracel-
lular membrane damage triggered by bacterial entry (Tattoli
et al., 2012; Thurston et al., 2012). Additionally, we show that
CLEC12A likely serves as an adaptor to help recruit ubiquitin
and NDP52 to sites of vacuolar damage caused by bacteria
and thus induce antibacterial autophagy. These data suggest
parallels between the functions of galectins and CLRs as early
sensors of damage in selective autophagy pathways. Addition-
ally, a dendritic cell CLR, DNGR-1, regulates endocytic handling
of necrotic cell antigens to modulate cross-priming, suggesting
that CLRs could function broadly in the selection of endocytic
cargo (Zelenay et al., 2012). Recent data also indicate a role
for another CLR, CLEC16A, in mitophagy, indicating that these
lectins can function broadly to control target selectivity in auto-
phagy (Soleimanpour et al., 2014).
Here, we integrated time course RNA-seq data and quantita-
tive proteomics to identify relevant CLEC12A-dependent protein
interactions that are involved in antibacterial autophagy. We
identified an E3 ligase complex including KLHL9, NEDD8, and
KLHL13 that interacts with CLEC12A and is required for antibac-
terial autophagy. Transcriptomic data suggested that the associ-
ation of CLEC12Awith this E3 ligase complex is important for the
CLEC12A-dependent response to bacterial infection. Virulence
factors produced by some bacteria are known to directly target
neddylated cullin-associated ubiquitin ligase activity, suggesting
that these proteins might be broadly involved in inhibiting bacte-
rial pathogenesis (Jubelin et al., 2010). Additionally, KLHL9 has
been previously associatedwith early onset autosomal dominant
distal myopathy, a disease in which alterations to the autophagy
pathway are thought to contribute to pathophysiology (Cirak
et al., 2010). Taken together, these data identify a role for the
recently evolved substrate adapters KLHL9 and KLHL13 as
well as NEDD8 in the restriction of bacterial infection.
Previous studies have suggested roles for the E3 ligases
SMURF1, LRSAM1, and PARKIN in pathogen-specific auto-
phagy (Huett et al., 2012; Manzanillo et al., 2013; Orvedahl
et al., 2011). Recent studies have also highlighted roles for other
E3 ubiquitin ligases in the control of bulk autophagy. These
include a role for RNF5 in regulating the levels of ATG4B (Kuang
et al., 2012), a role for Cullin-5 and Cullin-4 in autophagy regula-
tion through AMBRA1 (Antonioli et al., 2014), and a role for
RNF216 in autophagy regulation through Beclin1 (Xu et al.,
2014). Additionally, several members of the TRIM family of
proteins can act as a platform for assembly of the autophagyma-
chinery (Mandell et al., 2014). Expression of RNF5 and RNF216
were also shown to increase pathogen susceptibility through
autophagy (Kuang et al., 2012; Xu et al., 2014). Taken together
with our data, these findings demonstrate that E3 ubiquitin li-
gases play an important role in regulating autophagy at different
stages of the pathway. Specifically, E3 ubiquitin ligases create
selectivity in autophagy regulation by recognizing and inte-
grating specific signals from pathogens and cellular states. Uti-
lizing E3 ligases to tightly control the response to pathogens is
likely a highly conserved mechanism of innate defense (Pollier
et al., 2013).
Here, we use integrated genomics to demonstrate a role for
CLEC12A in antibacterial autophagy and identify an E3 ligase
complex that provides insight into the selectivity of pathogen
degradation. Our in vivo results highlight a strong role for
CLEC12A in the restriction of microbial replication. It is possible
given this dramatic effect that CLEC12A functions not only in
antibacterial autophagy but in other pathogen defense pathways
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as well. This study highlights how perturbational profiling can be
used to study pathways underlying immunity and pathogen de-
fense and illustrates the potential of combining whole-genome
experimental data sets to understand functional gene interac-
tions within a relevant pathway.
EXPERIMENTAL PROCEDURES
Isolation of PBMCs and Perturbation
For perturbational profiling, bloodwas collected after written informed consent
(or waiver as approved by the institutional review board) from healthy volun-
teers at Radboud University Nijmegen Medical Centre (RUNMC). The study
was approved by the institutional review boards and was performed in accor-
dance with the Declaration of Helsinki. Separation and stimulation of PBMCs
from healthy individuals was performed as described previously (Netea
et al., 2004). Microarray hybridization and genotyping of volunteers was per-
formed as previously described (Smeekens et al., 2013). Factorial design anal-
ysis was performed as described previously (Cadwell et al., 2010). See the
Supplemental Experimental Procedures for further details.
Antibacterial Autophagy Assays
S. Typhimurium infections of HeLa cells and gentamicin protection assays
were performed as previously described (Huett et al., 2012). For entry assays,
cells were infected for 20 min, washed, fixed in 4% paraformaldehyde for
15min at room temperature, and stained as described below. For antibacterial
autophagy assays in siRNA-treated cells, RNAi knockdown for 48 hr was per-
formed as described above on HeLa cells plated on glass coverslips and
infected as above. Infections of BMDMs with Listeria were performed with
strain EGDe. See the Supplemental Experimental Procedures for further
details.
Classical Autophagy Assay
Autophagy was induced in HeLa cells by treatment for 4 hr with 100 nM Torin-
1, 10 mg ml1 of E64d-Pepstatin A (Sigma-Aldrich), or mock treatment with
DMSO. Cells were treated with siRNA for 48 hr as described above and
then autophagy was induced followed by cell lysis (25 mM Tris [pH 7.5],
0.5% NP-40, 150 mM NaCl, and protease inhibitors [Roche]). Western
blotting to demonstrate LC3 lipidation was performed after equalization of
protein amounts and SDS-PAGE on an AnyKD polyacrylamide gel (Bio-
Rad). Following transfer to Immobilon-P membranes (Millipore), detection
was performed using rabbit anti-LC3 primary (Sigma-Aldrich), mouse anti-
actin (Sigma-Aldrich), and appropriate fluorescent secondary antibodies
(LI-COR Biosciences) as previously described.
Gentamicin Protection Assay
Bacterial survival assays were performed as previously described (Huett et al.,
2012; Lassen et al., 2014). See the Supplemental Experimental Procedures for
further details.
CRISPR ATG16L1 Knockout and Complementation
The second exon of ATG16L1 was targeted in HeLa cells using the px330
plasmid CRISPR system as described (Ran et al., 2013). See the Supplemental
Experimental Procedures for further details.
In Vivo Salmonella Infection
Mice were maintained in specific-pathogen-free facilities at Massachusetts
General Hospital. All animal studies were conducted under protocols
approved by the Subcommittee on Research Animal Care (SRAC) at Massa-
chusetts General Hospital.Clec12a/mice were obtained from the laboratory
of G.D.B. at the University of Aberdeen. Clec12a/ mice were produced by
conventional gene targeting of exons 1–4 on a C57BL/6 background (P. Rede-
linghuys, A. Augello, R.A. Drummond, J.-M. Levesque, S. Vautier, D.M. Reid,
B. Kerscher, J.A. Taylor, P.A. Nigrovic, J. Wright, G.I. Murray, L.J. Hocking,
M.J.G. Fernandes, C. De Bari, I.B. Mcinnes, and G.D.B., unpublished data).
Mice were born at Mendelian ratios. Protocols for bacterial growth and infec-
tion were performed as previously described, with slight modification (Barthel
et al., 2003; Conway et al., 2013). See the Supplemental Experimental Proce-
dures for further details.
Quantitative Proteomics
Quantitative proteomics using iTRAQ labeling of peptides was performed as
described previously (Lassen et al., 2014;Mertins et al., 2014). See the Supple-
mental Experimental Procedures for further details.
Osmotic Stress Assay
HeLa cells were reverse-transfected with plasmid expressing GFP-CLEC12A
on glass coverslips in 12-well plates the night before the assay. Osmotic lysis
of endosomes was accomplished by exposing cells to hypertonic medium
(0.5 M sucrose in PBS with 10% PEG100) for 10 min. Cells were washed twice
with 13 PBS and then incubated in 60%PBS for 3min as described previously
(Thurston et al., 2012). Cells were returned to complete medium for 20min and
then fixed with ice-cold methanol.
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